In Reply to Al-Rashdan

Investigator-initiated studies managed within the radiation oncology clinical research office and radiation oncology statistical team (Visualization Laboratory) undergo some of the strictest clinical trial oversights in the United States. It is unlikely that the level of underreporting is higher than in any comparable study.1 One of the major strengths of our study is the thorough follow-up and evaluation of the treated patients within the same health system and constant communication between all providers involved in the care, which should minimize underreporting of adverse events (AEs).
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Letter to the Editor Source Type: research